We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+6.97%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$977M
AUM Growth
+$61.2M
Cap. Flow
+$15.6M
Cap. Flow %
1.6%
Top 10 Hldgs %
35.78%
Holding
149
New
31
Increased
28
Reduced
46
Closed
17

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$17.7M
2
DELL icon
Dell
DELL
+$17.1M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$15.1M
4
PLGO
Pelagos Insurance Capital
PLGO
+$11.1M
5
CI icon
Cigna
CI
+$9.9M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$16M
2
LLY icon
Eli Lilly
LLY
+$15.2M
3
MSFT icon
Microsoft
MSFT
+$14M
4
UNH icon
UnitedHealth
UNH
+$11.2M
5
AAPL icon
Apple
AAPL
+$10.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.48%
2 Technology 20.72%
3 Healthcare 12.89%
4 Industrials 12%
5 Communication Services 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUMA icon
101
Humacyte
HUMA
$153M
$972K 0.1%
+178,768
New +$1.18M
BAC icon
102
Bank of America
BAC
$416B
$952K 0.1%
24,000
– –
PEP icon
103
PepsiCo
PEP
$185B
$942K 0.1%
5,540
– –
DOW icon
104
Dow Inc
DOW
$21.6B
$934K 0.1%
17,100
– –
BSX icon
105
Boston Scientific
BSX
$63.6B
$754K 0.08%
9,000
– –
REGN icon
106
Regeneron Pharmaceuticals
REGN
$79.7B
$752K 0.08%
715
– –
COST icon
107
Costco
COST
$400B
$748K 0.08%
+844
New +$733K
ORCL icon
108
Oracle
ORCL
$424B
$699K 0.07%
+4,100
New +$594K
STWD icon
109
Starwood Property Trust
STWD
$5.63B
$583K 0.06%
28,600
– –
HQL
110
abrdn Life Sciences Investors
HQL
$590M
$581K 0.06%
38,519
-36,110
-48% -$546K
HQH
111
abrdn Healthcare Investors
HQH
$1.22B
$581K 0.06%
31,187
-29,355
-48% -$547K
VICI icon
112
VICI Properties
VICI
$27.3B
$550K 0.06%
16,500
– –
RVTY icon
113
Revvity
RVTY
$15.6B
$549K 0.06%
+4,300
New +$506K
ILMN icon
114
Illumina
ILMN
$33.6B
$548K 0.06%
+4,200
New +$518K
MDT icon
115
Medtronic
MDT
$120B
$540K 0.06%
6,000
-6,900
-53% -$580K
KLAC icon
116
KLA
KLAC
$220B
$535K 0.05%
6,910
-5,450
-44% -$428K
GILD icon
117
Gilead Sciences
GILD
$181B
$528K 0.05%
6,300
– –
ARGX icon
118
argenx
ARGX
$61.3B
$485K 0.05%
895
– –
RDFN
119
DELISTED
Redfin
RDFN
$472K 0.05%
+37,664
New +$346K
T icon
120
AT&T
T
$183B
$447K 0.05%
20,300
-32,100
-61% -$639K
SPOT icon
121
Spotify
SPOT
$115B
$420K 0.04%
+1,140
New +$379K
FANG icon
122
Diamondback Energy
FANG
$59.2B
$415K 0.04%
2,409
-45
-2% -$8.66K
PRU icon
123
Prudential Financial
PRU
$41.2B
$400K 0.04%
3,300
– –
BMEZ icon
124
BlackRock Health Sciences Trust II
BMEZ
$1B
$380K 0.04%
24,000
-24,000
-50% -$378K
BRK.B icon
125
Berkshire Hathaway Class B
BRK.B
$1.11T
$355K 0.04%
771
-20
-3% -$8.84K
2 3 4
5
6

Similar funds

ACG
Allen Capital Group Grand Island, Nebraska $1.23B AUM 19.04% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return
CCFCSB
Cape Cod Five Cents Savings Bank Orleans, Massachusetts $1.23B AUM
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
OA
Oxbow Advisors Austin, Texas $1.23B AUM 23.59% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.23B AUM 15.23% 1-Year Est. Return
ZA
Zazove Associates Incline Village, Nevada $1.22B AUM 1.92% 1-Year Est. Return
WVUF
West Virginia University Foundation Morgantown, West Virginia $1.22B AUM 21.82% 1-Year Est. Return

Clough Capital Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Clough Capital Partners held 149 positions worth $977M, up 6.7% from $916M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Clough Capital Partners's Q3 2024 filing shows 31 new, 28 increased, 46 reduced and 17 closed positions. Its largest new stake was Bristol-Myers Squibb: 376,952 shares worth $19.5M. The largest sale was Merck, an estimated $16M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • Clough Capital Partners's largest Q3 2024 buy was Bristol-Myers Squibb: 376,952 shares worth $19.5M.
  • Clough Capital Partners added most to Dell in Q3 2024, an estimated $17.1M increase.
  • Clough Capital Partners's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $15.2M.
  • Clough Capital Partners fully exited Merck in Q3 2024, selling an estimated $16M.
  • Clough Capital Partners's ten largest holdings make up 36% of its $977M portfolio in Q3 2024.
  • Clough Capital Partners opened 31 new positions and closed 17 in Q3 2024.
  • Clough Capital Partners's portfolio value rose 6.7% quarter-over-quarter to $977M.

Based on Clough Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.